Silymarin increases the sensitivity of breast cancer cells to doxorubicin in doxorubicin-induced MCF-7 cells by inhibiting breast cancer resistance protein expression
Research output: Contribution to journal › Conference article › peer-review
4Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Silymarin increases the sensitivity of breast cancer cells to doxorubicin in doxorubicin-induced MCF-7 cells by inhibiting breast cancer resistance protein expression'. Together they form a unique fingerprint.